Incursions of Candida auris into Australia, 2018.

Australia Candida auris antimicrobial resistance fungi genomics infection control public health surveillance

Journal

Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155

Informations de publication

Date de publication:
06 2020
Historique:
pubmed: 28 3 2020
medline: 22 6 2021
entrez: 28 3 2020
Statut: ppublish

Résumé

Candida auris is an emerging global healthcare-associated pathogen. During July-December 2018, four patients with C. auris were identified in Victoria, Australia, all with previous overseas hospitalization. Phylogenetic analysis revealed putative transmission between 2 patients and suspected overseas acquisition in the others. Vigilant screening of at-risk patients is required.

Identifiants

pubmed: 32213261
doi: 10.3201/eid2606.190936
pmc: PMC7258446
doi:

Substances chimiques

Antifungal Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1326-1328

Références

Clin Infect Dis. 2017 Jan 15;64(2):134-140
pubmed: 27988485
PeerJ. 2018 Jan 3;6:e4210
pubmed: 29312831
Emerg Microbes Infect. 2018 Mar 29;7(1):43
pubmed: 29593275
Med J Aust. 2020 May 24;:
pubmed: 32447766

Auteurs

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH